Nexgen Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 08-12-2024
- Paid Up Capital ₹ 1.62 Cr
as on 08-12-2024
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.02 Cr
as on 08-12-2024
- Revenue -2.20%
(FY 2022)
- Profit 81.93%
(FY 2022)
- Ebitda 60.55%
(FY 2022)
- Net Worth -0.75%
(FY 2022)
- Total Assets -0.43%
(FY 2022)
About Nexgen Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.62 Cr.
The company has closed loans amounting to ₹3.02 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shraddha Dhamankar and Anilkumar Mulye serve as directors at the Company.
- CIN/LLPIN
U24230MH2004PTC148417
- Company No.
148417
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Sep 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nexgen Healthcare Private Limited offer?
Nexgen Healthcare Private Limited offers a wide range of products and services, including Pharmaceutical Machinery & Equipment, Tablet Testing System, Urological & Obstetrics Instruments, Gynaecological Equipment, Popular Category, Bone & Joint Care.
Who are the key members and board of directors at Nexgen Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shraddha Dhamankar  | Director | 06-Sep-2004 | Current |
| Anilkumar Mulye | Director | 11-Sep-2024 | Current |
Financial Performance and Corporate Structure Insights of Nexgen Healthcare.
Nexgen Healthcare Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.2% decrease. The company also saw a substantial improvement in profitability, with a 81.93% increase in profit. The company's net worth dipped by a decrease of 0.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nexgen Healthcare?
In 2022, Nexgen Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Enem Nostrum Remedies Private LimitedActive 23 years 11 monthsShraddha Dhamankar and Anilkumar Mulye are mutual person
- Nli Healthcare (India) Private LimitedActive 5 years 10 months
Shraddha Dhamankar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 14 Sep 2017 | ₹8.00 M | Satisfied |
Bank Of India Creation Date: 04 Oct 2016 | ₹1.20 M | Satisfied |
Bank Of India Creation Date: 28 Feb 2007 | ₹2.10 Cr | Satisfied |
How Many Employees Work at Nexgen Healthcare?
Nexgen Healthcare has a workforce of 5 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexgen Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexgen Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
